Nimbex (Cisatracurium Besilate)

Cisatracurium Besilate is used as a skeletal muscle relaxant during procedures that require neuromuscular blockade.

• Facilitation of endotracheal intubation: provides rapid muscle relaxation to enable safe tube placement.
• Skeletal muscle relaxation during surgery: maintains paralysis for optimal surgical conditions.
• Assistance with mechanical ventilation: supports patients on ventilators by preventing spontaneous breathing efforts.

• Cisatracurium Besilate acts as a competitive antagonist at nicotinic acetylcholine receptors on the motor end‑plate of skeletal muscle. By binding without activating the receptor, it blocks acetylcholine‑mediated depolarization, preventing muscle contraction and producing a dose‑dependent neuromuscular blockade. The drug is eliminated primarily by Hofmann degradation, a temperature‑ and pH‑dependent non‑enzymatic process that limits accumulation and allows a predictable offset of effect.

Cisatracurium Besilate may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Flushing: transient skin redness.
• Bradycardia: slowed heart rate.
• Hypotension: reduced blood pressure.
• Dry mouth: decreased salivation.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate intervention.
• Malignant hyperthermia‑like reaction: rare hypermetabolic state.
• Prolonged paralysis: extended neuromuscular blockade beyond expected duration.
• Respiratory depression: inadequate ventilation after drug effect.

Cisatracurium Besilate requires careful monitoring and specific safety measures.

• Monitoring neuromuscular function: use peripheral nerve stimulator to assess depth of block.
• Dose adjustment in renal or hepatic impairment: consider slower onset or prolonged effect.
• Avoid in patients with known hypersensitivity to cisatracurium or related compounds.
• Caution in patients with cardiovascular instability: may exacerbate hypotension or bradycardia.
• Concurrent use with other neuromuscular blockers: increase risk of additive paralysis.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Cisatracurium Besilate can interact with several drug classes, influencing its neuromuscular blocking profile.

Major Interactions (Avoid)

• Aminoglycoside antibiotics (e.g., gentamicin): potentiate neuromuscular blockade.
• Tetracycline antibiotics (e.g., doxycycline): enhance muscle relaxation.
• Magnesium sulfate: synergistic effect on blockade.

Moderate Interactions (Monitor Closely)

• Volatile anesthetics (e.g., sevoflurane): may increase duration of block.
• Lithium therapy: may prolong neuromuscular effects.
• Calcium channel blockers: possible additive hypotensive effect.